|
PSMF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.31739999999992E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.139210E-03 |
| Normal-vs-Stage2 |
8.075800E-01 |
| Normal-vs-Stage3 |
2.68329999997263E-07 |
| Normal-vs-Stage4 |
4.07970000000368E-05 |
| Stage1-vs-Stage2 |
3.911900E-02 |
| Stage1-vs-Stage3 |
5.983700E-03 |
| Stage1-vs-Stage4 |
5.067800E-02 |
| Stage2-vs-Stage3 |
2.616500E-04 |
| Stage2-vs-Stage4 |
2.259800E-03 |
| Stage3-vs-Stage4 |
8.997000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84089999999415E-06 |
| Normal-vs-AfricanAmerican |
1.336800E-01 |
| Normal-vs-Asian |
5.827400E-01 |
| Caucasian-vs-AfricanAmerican |
3.385400E-01 |
| Caucasian-vs-Asian |
5.099600E-03 |
| AfricanAmerican-vs-Asian |
3.692200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.4694999999948E-05 |
| Normal-vs-Female |
2.774500E-04 |
| Male-vs-Female |
3.316000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.537400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.416280E-04 |
| Normal-vs-Age(61-80Yrs) |
1.177440E-04 |
| Normal-vs-Age(81-100Yrs) |
1.370370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.539400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.338600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.625800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.284600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.075600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.738200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.601000E-04 |
| Classical-VS-Follicular |
1.473240E-01 |
| Classical-VS-Other |
8.604000E-02 |
| Classical-VS-Normal |
4.610400E-04 |
| Tall-VS-Follicular |
5.70909999999536E-05 |
| Tall-VS-Other |
8.877600E-01 |
| Tall-VS-Normal |
2.32060000104894E-08 |
| Follicular-VS-Other |
6.077700E-02 |
| Follicular-VS-Normal |
1.647950E-01 |
| Other-VS-Normal |
8.195400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.581500E-03 |
| Normal-vs-N1 |
5.10560000055449E-07 |
| N0-vs-N1 |
5.956500E-04 |
|
|
